Net Income per Share (Tables)

3 Months Ended

Mar. 31, 2017

Net Income per Share [Abstract]

Basic and Diluted Net Income per Share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):

	Three Months Ended
	March 31,
	2017		2016
Net income	$	2,709	$	5,406
Basic:
Weighted-average shares of common stock outstanding		33,383		33,911
Shares used in computing basic net income per share		33,383		33,911
Effect of dilutive securities:
Restricted stock subject to vesting		402		363
Contingently issuable shares (1)		-		7
Shares issuable for acquisition consideration (2)		509		561
Shares used in computing diluted net income per share		34,294		34,842
Basic net income per share	$	0.08	$	0.16
Diluted net income per share	$	0.08	$	0.16
Anti-dilutive restricted stock not included in the calculation of diluted net income per share		122		112

(1) For the three months ended March 31, 2016, this represents the Company’s estimate of shares to be issued to Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”) pursuant to the Asset Purchase Agreement.

(2) For the three months ended March 31, 2017, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with BioPharm Systems, Inc. (“BioPharm”); (ii) the Asset Purchase Agreement with Zeon; (iii) the Asset Purchase Agreement with The Pup Group, Inc. d/b/a Enlighten (“Enlighten”); and (iv) the Asset Purchase Agreement with RAS & Associates, LLC (“RAS”) as part of the consideration.  For the three months ended March 31, 2016, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with BioPharm; (ii) the Asset Purchase Agreement with Zeon; (iii) the Stock Purchase Agreement for Market Street Solutions, Inc. (“Market Street”); and (iv) the Asset Purchase Agreement with Enlighten as part of the consideration.